These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 19788935
1. Oral administration of xanthan gum enhances antitumor activity through Toll-like receptor 4. Takeuchi A, Kamiryou Y, Yamada H, Eto M, Shibata K, Haruna K, Naito S, Yoshikai Y. Int Immunopharmacol; 2009 Dec; 9(13-14):1562-7. PubMed ID: 19788935 [Abstract] [Full Text] [Related]
2. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. Sawaki J, Tsutsui H, Hayashi N, Yasuda K, Akira S, Tanizawa T, Nakanishi K. Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654 [Abstract] [Full Text] [Related]
3. MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans. Biondo C, Midiri A, Messina L, Tomasello F, Garufi G, Catania MR, Bombaci M, Beninati C, Teti G, Mancuso G. Eur J Immunol; 2005 Mar; 35(3):870-8. PubMed ID: 15714580 [Abstract] [Full Text] [Related]
4. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes. Romics L, Dolganiuc A, Velayudham A, Kodys K, Mandrekar P, Golenbock D, Kurt-Jones E, Szabo G. J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620 [Abstract] [Full Text] [Related]
5. Toll-like receptor 4 mediates an antitumor host response induced by Salmonella choleraesuis. Lee CH, Wu CL, Shiau AL. Clin Cancer Res; 2008 Mar 15; 14(6):1905-12. PubMed ID: 18347194 [Abstract] [Full Text] [Related]
6. MyD88-dependent Toll-like receptor signaling is required for murine macrophages response to IS2. Li H, Kim WJ, Jiang J, Lee SH, Youn HS, Moon EY, Kim TJ, Ye SK, Ryu JH, Kang TB, Koppula S, Park PJ, Choi DK, Lee KH. Int Immunopharmacol; 2011 Oct 15; 11(10):1578-83. PubMed ID: 21628003 [Abstract] [Full Text] [Related]
7. Methods of in vitro macrophage maturation confer variable inflammatory responses in association with altered expression of cell surface dectin-1. Gersuk GM, Razai LW, Marr KA. J Immunol Methods; 2008 Jan 01; 329(1-2):157-66. PubMed ID: 17997408 [Abstract] [Full Text] [Related]
8. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice. Jung YO, Cho ML, Lee SY, Oh HJ, Park JS, Park MK, Park MJ, Ju JH, Kim SI, Park SH, Kim HY, Min JK. Immunol Lett; 2009 Apr 27; 123(2):138-43. PubMed ID: 19428561 [Abstract] [Full Text] [Related]
9. Melanoma inhibits macrophage activation by suppressing toll-like receptor 4 signaling. Clarke JH, Cha JY, Walsh MD, Gamboni-Robertson F, Banerjee A, Reznikov LL, Dinarello CA, Harken AH, McCarter MD. J Am Coll Surg; 2005 Sep 27; 201(3):418-25. PubMed ID: 16125076 [Abstract] [Full Text] [Related]
10. MyD88 is dispensable for resistance to Paracoccidioides brasiliensis in a murine model of blood-borne disseminated infection. González A, Yáñez A, Gozalbo D, Gil ML. FEMS Immunol Med Microbiol; 2008 Dec 27; 54(3):365-74. PubMed ID: 19049649 [Abstract] [Full Text] [Related]
11. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects. Osaki T, Péron JM, Cai Q, Okamura H, Robbins PD, Kurimoto M, Lotze MT, Tahara H. J Immunol; 1998 Feb 15; 160(4):1742-9. PubMed ID: 9469432 [Abstract] [Full Text] [Related]
12. TLR2-, TLR4- and Myd88-independent acquired humoral and cellular immunity against Salmonella enterica serovar Typhimurium. Seibert SA, Mex P, Köhler A, Kaufmann SH, Mittrücker HW. Immunol Lett; 2010 Jan 04; 127(2):126-34. PubMed ID: 19895846 [Abstract] [Full Text] [Related]
14. Roles of the small intestine for induction of toll-like receptor 4-mediated innate resistance in naturally acquired murine toxoplasmosis. Furuta T, Kikuchi T, Akira S, Watanabe N, Yoshikawa Y. Int Immunol; 2006 Dec 04; 18(12):1655-62. PubMed ID: 17035347 [Abstract] [Full Text] [Related]
15. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively. Hashimoto W, Osaki T, Okamura H, Robbins PD, Kurimoto M, Nagata S, Lotze MT, Tahara H. J Immunol; 1999 Jul 15; 163(2):583-9. PubMed ID: 10395644 [Abstract] [Full Text] [Related]
16. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. Netea MG, Van Der Graaf CA, Vonk AG, Verschueren I, Van Der Meer JW, Kullberg BJ. J Infect Dis; 2002 May 15; 185(10):1483-9. PubMed ID: 11992285 [Abstract] [Full Text] [Related]
17. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. Arthritis Rheum; 2005 Sep 15; 52(9):2936-46. PubMed ID: 16142712 [Abstract] [Full Text] [Related]
18. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Toshchakov V, Jones BW, Perera PY, Thomas K, Cody MJ, Zhang S, Williams BR, Major J, Hamilton TA, Fenton MJ, Vogel SN. Nat Immunol; 2002 Apr 15; 3(4):392-8. PubMed ID: 11896392 [Abstract] [Full Text] [Related]
19. Regulatory effects of Spirulina complex polysaccharides on growth of murine RSV-M glioma cells through Toll-like receptor 4. Kawanishi Y, Tominaga A, Okuyama H, Fukuoka S, Taguchi T, Kusumoto Y, Yawata T, Fujimoto Y, Ono S, Shimizu K. Microbiol Immunol; 2013 Jan 15; 57(1):63-73. PubMed ID: 23134155 [Abstract] [Full Text] [Related]
20. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation. Okamoto M, Furuichi S, Nishioka Y, Oshikawa T, Tano T, Ahmed SU, Takeda K, Akira S, Ryoma Y, Moriya Y, Saito M, Sone S, Sato M. Cancer Res; 2004 Aug 01; 64(15):5461-70. PubMed ID: 15289356 [Abstract] [Full Text] [Related] Page: [Next] [New Search]